JP2002542342A5
(enExample )
2007-06-07
JP2006512924A5
(enExample )
2007-02-15
JP2004538039A5
(enExample )
2007-11-29
JP2006520339A5
(enExample )
2006-10-19
JP2007510619A5
(enExample )
2007-11-29
EP2201945A3
(en )
2010-07-21
Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
CA2168016A1
(en )
1995-12-07
Benzimidazole Derivatives
EP2189439A3
(en )
2011-05-04
CaSR antagonist
JP2003528020A5
(enExample )
2008-05-01
JP2003160581A5
(enExample )
2005-06-09
JPH10235999A5
(enExample )
2004-08-12
JPH10218844A5
(enExample )
2005-01-06
CA2272014A1
(en )
1999-11-14
N-aryl/heteroaryl-substituted heterocycles
JPH1053941A5
(enExample )
2005-04-07
JP2002050481A5
(enExample )
2007-09-13
EP1074539A3
(en )
2004-07-14
Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
JP2002519409A5
(enExample )
2006-04-06
EP1676827A3
(en )
2006-07-26
Method for manufacturing 3-alkoxy-2-halogenocyclobutanone derivatives
JPH1095733A5
(enExample )
2005-04-07
JPH10152487A5
(enExample )
2005-02-17
JP2001055597A5
(enExample )
2007-08-30
EP2527353A3
(en )
2013-07-10
Caprazol derivatives
EP1683782A3
(en )
2007-03-28
Chiral copper complex and production processes thereof and using the same
JP2003514806A5
(enExample )
2007-12-13
JP2007503406A5
(enExample )
2007-08-23